Roth, Annika
ORCID: 0000-0002-3376-0968, Lütke, Steffen
ORCID: 0000-0001-6924-7990, Mörgelin, Matthias, Meinberger, Denise
ORCID: 0000-0002-7786-6000, Hermes, Gabriele, Sengle, Gerhard
ORCID: 0000-0003-3932-1242, Koch, Manuel
ORCID: 0000-0002-2962-7814, Drexelius, Marco
ORCID: 0000-0002-5813-2116, Gebauer, Jan
ORCID: 0000-0002-3989-4748, Neundorf, Ines
ORCID: 0000-0001-6450-3991, Elezagic, Dzemal
ORCID: 0000-0003-1041-8470, Paulsson, Mats
ORCID: 0000-0002-6846-857X, Streichert, Thomas
ORCID: 0000-0002-6588-720X and Klatt, Andreas R.
ORCID: 0000-0002-8517-7512
(2025).
Vitamin D-inducible antimicrobial peptide LL-37 binds SARS-CoV-2 Spike and accessory proteins ORF7a and ORF8.
Frontiers in Cellular and Infection Microbiology, 15.
Frontiers.
ISSN 2235-2988
|
PDF
fcimb-15-1671738.pdf Bereitstellung unter der CC-Lizenz: Creative Commons Attribution. Download (10MB) |
Abstract
[Artikel-Nr. 1671738] Background: The role of vitamin D in Coronavirus Disease 2019 (COVID-19) outcomes remains debated, but emerging evidence suggests it may enhance recovery by strengthening immune responses. Vitamin D upregulates LL-37, an antimicrobial peptide with broad antiviral activity, including potential benefits against SARS-CoV-2. LL-37’s interactions with viral proteins, however, remain incompletely understood. Methods: We investigated LL-37’s interactions with the SARS-CoV-2 Spike glycoprotein and the accessory proteins ORF7a and ORF8 using surface plasmon resonance and negative-stain electron microscopy. These approaches were employed to assess LL-37’s binding capabilities and potential impact on viral infectivity. Results: LL-37 bound multiple domains of the Spike protein and inhibited its interaction with the human angiotensin-converting enzyme 2 (hACE2) receptor in vitro . Up to seven LL-37 molecules were observed surrounding Spike, forming a halo-like structure that may block receptor engagement. LL-37 also bound to ORF7a and ORF8, potentially impairing their ability to disrupt host cell processes. Notably, LL-37’s interaction with ORF7a may prevent degradation of SNAP29, restoring autophagy and promoting viral clearance. Conclusions: LL-37 disrupts key viral-host interactions by binding to Spike, ORF7a, and ORF8, thereby reducing SARS-CoV-2 infectivity. These findings highlight LL-37’s potential as a therapeutic agent in COVID-19 and provide mechanistic insight into its antiviral actions.
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
![]() |
View Item |
https://orcid.org/0000-0002-3376-0968